ArticleBMC cancer2025

The impact of EGFR mutation and PD-L1 status on the efficacy of postoperative radiotherapy in stage III-pN2 NSCLC.

Jinquan Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.